Biocon Biologics
Raja Sekhar Reddy Vanga has an extensive background in international regulatory affairs for biosimilar and biological products. With experience in various managerial roles at Biocon Biologics, Biocon, USV LIMITED, VIRCHOW Biotech (P) LTD, and VINS BIOPRODUCTS LTD, Vanga has been involved in guiding quality aspects, regulatory science, and QA/QC functions in the pharmaceutical industry. Holding a M.SC in biotechnology from Andhra University and a graduation degree in Microbiology, Biochemistry, and Applied Nutrition from Nagarjuna University, Vanga is well-equipped with the knowledge and experience needed for their current position as Vice President - Global Regulatory Affairs at Biocon Biologics.
This person is not in the org chart
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics